subsidiaries (14.60) (9.03) 0.05 Profit(Loss) attributable to equity holders of the company (68.68) (42.47) (9.41) (38.21) (59.27) 629.86 Basic Loss Per Share (THB) (0.09) (0.02) Book Value per Share (THB) 0.46
follows: Operating Result Company’s Financial Statement in the Quarter 1/2019 has net loss amount to Baht 6.21 million or Baht 0.35 per share compared to the net loss of Baht 21.55 million in the Quarter 1
) (68.72) 311.51 Basic Loss Per Share (THB) (0.12) (0.04) Book Value per Share (THB) 0.12 0.32 30/06/2562 % 31/12/2561 % เพิม่/(ลด) % Current Asset 308.86 31,841.24 362.95 25,381.12 (54.09) (14.90) Non
: Operating Result Company’s Financial Statement in the Quarter 2/2019 has net profit amount to Baht 1.56 million or Baht 0.09 per share compared to the net loss of Baht 7.39 million in the Quarter 2/2018. Our
with the investment value. In case that the company increases its capital, such capital increase shall be done before the transfer of share to Yunnan Water (Hong Kong) Company Limited (YUNNAN). 2/3 เลข
important essence as follows: Operating Result Company’s Financial Statement in the Quarter 1/2018 has net loss amount to Baht 21.5 million or Baht 1.22 per share compared to the net loss of Baht 9.4 million
important essence as follows: Operating Result Company’s Financial Statement in the Quarter 2/2018 has net loss amount to Baht 7.4 million or Baht 0.42 per share compared to the net loss of Baht 9.8 million
Baht 939.87 million and new share issuance for capital increase of Baht 55 million. Please be informed accordingly. Yours sincerely, Miss Supamas Isarapakdi Chief Executive Officer DOD Biotech Public
can be summarized the important essence as follows: Operating Result Company’s Financial Statement in the Quarter 3/2018 has net profit amount to Baht 21.99 million or Baht 1.25 per share compared to
announced its interim dividend payment for the operating results of the year 2019 at the rate of 1.48 Baht per share; the payment was scheduled on 8 May 2020. It has also announced the interim dividend